Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Beam Therapeutics (NasdaqGS:BEAM) launched BEAM-304, a new ...
Beam Therapeutics is a leading biotech firm focused on precision genetic medicine with applications in hematology, immunology, oncology, and genetic diseases. Beam's stock assessment shows mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results